Neurosterix
Neurosterix is a biopharmaceutical firm dedicated to creating allosteric modulators for the treatment of neurological illnesses.
Based based in Europe, Middle East, and Africa (EMEA), Neurosterix works in biopharma, medical, founded in 2024.
The company sits in the biopharma, medical segment, where it competes on its core product or service.
Europe, Middle East, and Africa (EMEA) is where the company is located.
Its current recorded stage is Series_A.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $63M.
| Sector | Biopharma, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2024 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $63,000,000 |
Website: www.neurosterix.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account